PSEN1

Revision as of 14:42, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:PBB

WikiDoc Resources for PSEN1

Articles

Most recent articles on PSEN1

Most cited articles on PSEN1

Review articles on PSEN1

Articles on PSEN1 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on PSEN1

Images of PSEN1

Photos of PSEN1

Podcasts & MP3s on PSEN1

Videos on PSEN1

Evidence Based Medicine

Cochrane Collaboration on PSEN1

Bandolier on PSEN1

TRIP on PSEN1

Clinical Trials

Ongoing Trials on PSEN1 at Clinical Trials.gov

Trial results on PSEN1

Clinical Trials on PSEN1 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on PSEN1

NICE Guidance on PSEN1

NHS PRODIGY Guidance

FDA on PSEN1

CDC on PSEN1

Books

Books on PSEN1

News

PSEN1 in the news

Be alerted to news on PSEN1

News trends on PSEN1

Commentary

Blogs on PSEN1

Definitions

Definitions of PSEN1

Patient Resources / Community

Patient resources on PSEN1

Discussion groups on PSEN1

Patient Handouts on PSEN1

Directions to Hospitals Treating PSEN1

Risk calculators and risk factors for PSEN1

Healthcare Provider Resources

Symptoms of PSEN1

Causes & Risk Factors for PSEN1

Diagnostic studies for PSEN1

Treatment of PSEN1

Continuing Medical Education (CME)

CME Programs on PSEN1

International

PSEN1 en Espanol

PSEN1 en Francais

Business

PSEN1 in the Marketplace

Patents on PSEN1

Experimental / Informatics

List of terms related to PSEN1


Presenilin 1 (Alzheimer disease 3), also known as PSEN1, is a human gene.

Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma secretase activity or themselves are protease enzymes. Multiple alternatively spliced transcript variants have been identified for this gene, the full-length natures of only some have been determined.[1]

References

  1. "Entrez Gene: PSEN1 presenilin 1 (Alzheimer disease 3)".

Further reading

  • Cruts M, Hendriks L, Van Broeckhoven C (1997). "The presenilin genes: a new gene family involved in Alzheimer disease pathology". Hum. Mol. Genet. 5 Spec No: 1449–55. PMID 8875251.
  • Cruts M, Van Broeckhoven C (1998). "Presenilin mutations in Alzheimer's disease". Hum. Mutat. 11 (3): 183–90. doi:10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J. PMID 9521418.
  • Larner AJ, Doran M (2006). "Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene". J. Neurol. 253 (2): 139–58. doi:10.1007/s00415-005-0019-5. PMID 16267640.
  • Wolfe MS (2007). "When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease". EMBO Rep. 8 (2): 136–40. doi:10.1038/sj.embor.7400896. PMID 17268504.
  • De Strooper B (2007). "Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease". EMBO Rep. 8 (2): 141–6. doi:10.1038/sj.embor.7400897. PMID 17268505.



Template:WH Template:WS